US4581401001 - Common Stock

29 **+1.6 (+5.84%) **

After market: 28.9399 -0.06 (-0.21%)

Taking everything into account, **INTC** scores **2** out of 10 in our fundamental rating. **INTC** was compared to 105 industry peers in the **Semiconductors & Semiconductor Equipment** industry. **INTC** has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, **INTC** is valued expensive at the moment.

*Note: INTC has only limited data available, so a full analysis was not possible, which makes the total rating unfair.*

The Piotroski-F score of **INTC** is **2.00**. This is a very weak score and indicates problems in health and profitability for **INTC**.

Compared to an average industry price book ratio of 3.67, **INTC** is valued rather cheaply. On top of this, **INTC** is cheaper than **90%** of the companies listed in the same industry.

When comparing the **Enterprise Value to EBITDA** ratio of **INTC** to the average industry ratio of 14.47, **INTC** is valued rather cheaply.

The **Forward Price/Earnings Ratio** of **15.18** indicates a correct valuation of **INTC**.

When comparing the current price to the book value of **INTC**, we can conclude it is valued correctly. It is trading at **1.23** times its book value.

The **Price/Earnings Ratio** is **30.85**, which means the current valuation is very expensive for **INTC**.

Price/Earnings (30.85) VS Industry: 34% outperformed.

450.50

1.85

Price/Book (1.23) VS Industry: 90% outperformed.

100.79

0.31

Enterprise Value/ EBITDA (12.62) VS Industry: 62% outperformed.

1,084.83

2.76

The **Earnings Per Share** is expected to grow by **18.06%** on average over the next 5 years. This is quite good.

When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.

The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.

Measured over the past 5 years, **INTC** shows a small growth in **Revenue**. The Revenue has been growing by **0.09%** on average per year.

The **Revenue** is expected to grow by **5.62%** on average over the next 5 years.

Measured over the past 5 years, **INTC** shows a very negative growth in **Earnings Per Share**. The EPS has been decreasing by **-11.82%** on average per year.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | -11.82% | -27.68% | -81.01% | -71.21% | 1.61% | 13.84% | 18.06% |

Revenue | 0.09% | -4.31% | -27.4% | -20.1% | -4.05% | 0.71% | 5.62% |

A Current Ratio of **1.76** indicates that **INTC** should not have too much problems paying its short term obligations.

A Quick Ratio of **1.29** indicates that **INTC** should not have too much problems paying its short term obligations.

When comparing the Current Ratio of **INTC** to the average industry Current Ratio of **3.36**, **INTC** is less able to pay its short term obligations than its industry peers. **84%** of its industry peers have a better Current Ratio.

When comparing the Quick Ratio of **INTC** to the average industry Current Ratio of **2.39**, **INTC** is less able to pay its short term obligations than its industry peers. **82%** of its industry peers have a better Quick Ratio.

When comparing the Debt to Equity Ratio of **INTC** to the average industry Debt to Equity Ratio of **0.14**, **INTC** required more debt to finance its operations than its industry peers.

Compared to an average industry Altman-Z score of **4.86**, **INTC** is in worse financial health than its industry peers.

The Piotroski-F score of **INTC** is **2.00**. This is a very weak score and indicates problems in health and profitability for **INTC**.

Debt/Equity (0.5) VS Industry: 27% outperformed.

23.26

0.00

Quick Ratio (1.29) VS Industry: 18% outperformed.

0.28

24.06

Current Ratio (1.76) VS Industry: 16% outperformed.

0.43

26.44

Altman-Z (1.73) VS Industry: 24% outperformed.

-35.76

123.42

The dividend of **INTC** is nicely growing with an annual growth rate of **6.29%**!

With a **Yearly Dividend Yield** of **1.82%**, **INTC** has a reasonable but not impressive dividend return.

The dividend of **INTC** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

Dividend Yield (1.82%) VS Industry: 56% outperformed.

0.04

8.11

**INTEL CORP**

NASDAQ:INTC (5/26/2023, 7:00:03 PM)

After market: 28.9399 -0.06 (-0.21%)**29**

**+1.6 (+5.84%) **

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupSemiconductors & Semiconductor Equipment

GICS IndustrySemiconductors & Semiconductor Equipment

Earnings (Last)04-27 2023-04-27/amc

Earnings (Next)07-26 2023-07-26/amc

Inst Owners61.93%

Inst Owner Change-0.82%

Ins Owners0.02%

Ins Owner Change26.29%

Market Cap120.96B

Analysts56.17

Price Target31.22 (7.66%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.82% |

Dividend Growth(5Y)6.29%

DP-210.78%

Div Incr Years8

Div Non Decr Years19

Ex-Date05-04 2023-05-04 (0.125)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)11.18%

Min EPS beat(2)-51.67%

Max EPS beat(2)74.04%

EPS beat(4)2

Avg EPS beat(4)10.34%

Min EPS beat(4)-59.12%

Max EPS beat(4)78.13%

Revenue beat(2)1

Avg Revenue beat(2)-0.47%

Min Revenue beat(2)-4.76%

Max Revenue beat(2)3.82%

Revenue beat(4)1

Avg Revenue beat(4)-4.64%

Min Revenue beat(4)-16.2%

Max Revenue beat(4)3.82%

PT rev (1m)6.3%

PT rev (3m)11.16%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-56.94%

EPS NY rev (1m)0%

EPS NY rev (3m)-72.22%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-1.15%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-16.83%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 30.85 | ||

Fwd PE | 15.18 | ||

P/S | 2.14 | ||

P/FCF | N/A | ||

P/OCF | 15.59 | ||

P/B | 1.23 | ||

P/tB | 1.86 | ||

EV/EBITDA | 12.62 |

EPS(TTM)0.94

EY3.24%

EPS(NY)1.91

Fwd EY6.59%

FCF(TTM)-4.77

FCFYN/A

OCF(TTM)1.86

OCFY6.41%

SpS13.53

BVpS23.51

TBVpS15.56

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | N/A | ||

ROE | N/A | ||

ROIC | N/A | ||

ROICexc | N/A | ||

ROICexgc | N/A | ||

OM | N/A | ||

PM | N/A | ||

GM | 38.34% |

ROICexgc(3y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc(3y)N/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-50.83%

OM growth 5Y-33.91%

PM growth 3Y-24.26%

PM growth 5Y-3.64%

GM growth 3Y-10.06%

GM growth 5Y-7.32%

F-Score2

Asset Turnover0.3

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.5 | ||

Debt/FCF | N/A | ||

Debt/EBITDA | 5.1 | ||

Cap/Depr | 229.54% | ||

Profit Quality | N/A | ||

Current Ratio | 1.76 | ||

Quick Ratio | 1.29 | ||

Altman-Z | 1.73 |

F-Score2

WACC10.15%

ROIC/WACCN/A

Cap/Depr(3y)160.36%

Cap/Depr(5y)159.59%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y-81.01%

EPS 3Y-27.68%

EPS 5Y-11.82%

EPS growth Q2Q-104.6%

EPS Next Y-71.21%

EPS Next 2Y1.61%

EPS Next 3Y13.84%

EPS Next 5Y18.06%

Revenue growth 1Y-27.4%

Revenue growth 3Y-4.31%

Revenue growth 5Y0.09%

Revenue growth Q2Q-36.17%

Revenue Next Year-20.1%

Revenue Next 2Y-4.05%

Revenue Next 3Y0.71%

Revenue Next 5Y5.62%

EBIT growth 1Y-111.38%

EBIT growth 3Y-52.95%

EBIT growth 5Y-33.84%

EBIT Next Year33%

EBIT Next 3Y37.17%

EBIT Next 5Y31.17%

FCF growth 1Y-200.49%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-77.69%

OCF growth 3Y-22.49%

OCF growth 5Y-6.94%

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*